ASHPOfficial

Faculty from our Summer Meeting symposium on COVID-19 in the immunocompromised population discuss new information and recommendation updates that have occurred since their initial presentation.  

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This three-part podcast series is a follow-up to the June 2022 ASHP continuing education webinar, “Things Not Often Taught in School: Embracing Vulnerable Populations in Ambulatory Care.” Each podcast series will feature one webinar speaker with additional information about working with the medically underserved, refugees & immigrants, and sexual & gender minorities.  

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this podcast, Dr. Lea Eiland, Dr. Meghan Swarthout, and Sara White discuss the AJHP Commentary, “Women in pharmacy leadership: The journey continues,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

ASHP conducted two surveys in late 2021 better understand how ASHP can promote technician development through the advancement of patient care roles and increased responsibilities, and address recruitment and retention issues within the technician workforce. Executive Committee Members of the Pharmacy Technician Forum and Section of Pharmacy Practice Leaders met during the 2022 ASHP Summer Meetings in Phoenix, AZ to reflect on the key findings identified from these surveys. 

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this Pharmacy Leadership Episode, Melanie Smith sits down with the Section of Ambulatory Care Practitioners 2022 Awardee, Mollie Ashe Scott, to discuss what membership within the Section and ASHP means to her and how it has helped her develop as a pharmacy practice leader. 

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast is very relevant to pharmacists who frequently treat patients or interact with patients in pain. Not all pharmacists are intimately familiar with the FDA’s Opioid Analgesic Risk Evaluation and Mitigation Strategy (REMS), which is the official comprehensive pain education strategy essential to frontline providers in order to ensure that patients receive and understand the Medication Guides and information regarding safe use of opioid medications.  

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Undecided about your career path? From clinical to specialty pharmacy, informatics to ambulatory care — the options seem endless. In the Career Pearls for Students podcast series you will hear from pharmacists who work in various pharmacy practice settings to learn more about what a day in the life is like. Take away information about careers you have interest in but never took the time to learn about — you may even find something you never knew existed. 

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Hajer Ibrahum was part of a pharmacist-led 10-session Transgender Men Health Education Group integrating gender-affirming and mental health topics was created.  In the episode, she shares her team-based approach to caring for this patient populations and identifying mental health barriers to receiving care.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

The opioid epidemic continues to be problematic across the country with increases in deaths from addiction leading to overdose. In an effort to minimize use of opioids postoperatively, the ERAS society developed guidelines and protocols pre-,intra-, and postoperatively to enhance recovery from surgical procedures while limiting use of opioids. Pharmacists play an integral part in the development of individual  hospital protocols for ERAS, monitoring patients postoperatively, and preparing appropriate and individualized regimens for pain management on discharge.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Tom Kraus, Vice President of ASHP Office of Government Relations, discusses with current members of the Advancement of Professional Practice Advisory Group how and why students should get involved with state and federal advocacy efforts, as well as how local SSHP chapters can help their members to advocate for the profession.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.